Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Eur J Med Chem ; 182: 111610, 2019 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-31434040

RESUMEN

Drug therapy for Chagas disease remains a major challenge as potential candidate drugs have failed clinical trials. Currently available drugs have limited efficacy and induce serious side effects. Thus, the discovery of new drugs is urgently needed in the fight against Chagas' disease. Here, we synthesized and evaluated the biological effect of pyrazole-imidazoline (1a-i) and pyrazole-tetrahydropyrimidine (2a-i) derivatives against relevant clinical forms of Trypanosoma cruzi. The structure-activity relationship (SAR), drug-target search, physicochemical and ADMET properties of the major active compounds in vitro were also assessed in silico. Pyrazole derivatives showed no toxicity in Vero cells and also no cardiotoxicity. Phenotypic screening revealed two dichlorinated pyrazole-imidazoline derivatives (1c and 1d) with trypanocidal activity higher than that of benznidazole (Bz) against trypomastigotes; these were also the most potent compounds against intracellular amastigotes. Replacement of imidazoline with tetrahydropyrimidine in the pyrazole compounds completely abolished the trypanocidal activity of series 2(a-i) derivatives. The physicochemical and ADMET properties of the compounds predicted good permeability, good oral bioavailability, no toxicity and mutagenicity of 1c and 1d. Pyrazole nucleus had high frequency hits for cruzipain in drug-target search and structure activity relationship (SAR) analysis of pyrazole-imidazoline derivatives revealed enhanced activity when chlorine atom was inserted in meta-positions of the benzene ring. Additionally, we found evidence that both compounds (1c and 1d) have the potential to interact non-covalently with the active site of cruzipain and also inhibit the cysteine proteinase activity of T. cruzi. Collectively, the data presented here reveal pyrazole derivatives with promise for further optimization in the therapy of Chagas disease.


Asunto(s)
Enfermedad de Chagas/tratamiento farmacológico , Imidazolinas/farmacología , Pirazoles/farmacología , Pirimidinas/farmacología , Tripanocidas/farmacología , Trypanosoma cruzi/efectos de los fármacos , Animales , Células Cultivadas , Chlorocebus aethiops , Relación Dosis-Respuesta a Droga , Humanos , Imidazolinas/química , Estructura Molecular , Pruebas de Sensibilidad Parasitaria , Pirazoles/química , Pirimidinas/química , Relación Estructura-Actividad , Tripanocidas/síntesis química , Tripanocidas/química , Células Vero
2.
Parasitology ; 140(2): 171-80, 2013 02.
Artículo en Inglés | MEDLINE | ID: mdl-22975090

RESUMEN

Heparin-binding proteins (HBPs) play a key role in Trypanosoma cruzi-host cell interactions. HBPs recognize heparan sulfate (HS) at the host cell surface and are able to induce the cytoadherence and invasion of this parasite. Herein, we analysed the biochemical properties of the HBPs and also evaluated the expression and subcellular localization of HBPs in T. cruzi trypomastigotes. A flow cytometry analysis revealed that HBPs are highly expressed at the surface of trypomastigotes, and their peculiar localization mainly at the flagellar membrane, which is known as an important signalling domain, may enhance their binding to HS and elicit the parasite invasion. The plasmon surface resonance results demonstrated the stability of HBPs and their affinity to HS and heparin. Additionally, gelatinolytic activities of 70 kDa, 65·8 kDa and 59 kDa HBPs over a broad pH range (5·5-8·0) were revealed using a zymography assay. These proteolytic activities were sensitive to serine proteinase inhibitors, such as aprotinin and phenylmethylsulfonyl fluoride, suggesting that HBPs have the properties of trypsin-like proteinases.


Asunto(s)
Membrana Celular/metabolismo , Flagelos/enzimología , Proteínas Protozoarias/metabolismo , Serina Proteasas/metabolismo , Trypanosoma cruzi/fisiología , Membrana Celular/enzimología , Activación Enzimática/efectos de los fármacos , Citometría de Flujo , Gelatina/metabolismo , Regulación de la Expresión Génica , Heparina/metabolismo , Interacciones Huésped-Parásitos , Concentración de Iones de Hidrógeno , Unión Proteica , Inhibidores de Serina Proteinasa/farmacología , Trypanosoma cruzi/enzimología
3.
Parasitology ; 139(6): 735-43, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22310218

RESUMEN

Heparin-binding proteins (HBPs) have been demonstrated in both infective forms of Trypanosoma cruzi and are involved in the recognition and invasion of mammalian cells. In this study, we evaluated the potential biological function of these proteins during the parasite-vector interaction. HBPs, with molecular masses of 65·8 kDa and 59 kDa, were isolated from epimastigotes by heparin affinity chromatography and identified by biotin-conjugated sulfated glycosaminoglycans (GAGs). Surface plasmon resonance biosensor analysis demonstrated stable receptor-ligand binding based on the association and dissociation values. Pre-incubation of epimastigotes with GAGs led to an inhibition of parasite binding to immobilized heparin. Competition assays were performed to evaluate the role of the HBP-GAG interaction in the recognition and adhesion of epimastigotes to midgut epithelial cells of Rhodnius prolixus. Epithelial cells pre-incubated with HBPs yielded a 3·8-fold inhibition in the adhesion of epimastigotes. The pre-treatment of epimastigotes with heparin, heparan sulfate and chondroitin sulfate significantly inhibited parasite adhesion to midgut epithelial cells, which was confirmed by scanning electron microscopy. We provide evidence that heparin-binding proteins are found on the surface of T. cruzi epimastigotes and demonstrate their key role in the recognition of sulfated GAGs on the surface of midgut epithelial cells of the insect vector.


Asunto(s)
Células Epiteliales/parasitología , Heparina/metabolismo , Interacciones Huésped-Parásitos , Proteínas Protozoarias/farmacología , Rhodnius/parasitología , Trypanosoma cruzi/fisiología , Animales , Adhesión Celular/efectos de los fármacos , Adhesión Celular/fisiología , Tracto Gastrointestinal/citología , Tracto Gastrointestinal/parasitología , Proteínas Protozoarias/metabolismo , Trypanosoma cruzi/crecimiento & desarrollo
4.
Parasitology ; 138(5): 593-601, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21269549

RESUMEN

Cell surface glycosaminoglycans (GAGs) play an important role in the attachment and invasion process of a variety of intracellular pathogens. We have previously demonstrated that heparan sulfate proteoglycans (HSPG) mediate the invasion of trypomastigote forms of Trypanosoma cruzi in cardiomyocytes. Herein, we analysed whether GAGs are also implicated in amastigote invasion. Competition assays with soluble GAGs revealed that treatment of T. cruzi amastigotes with heparin and heparan sulfate leads to a reduction in the infection ratio, achieving 82% and 65% inhibition of invasion, respectively. Other sulfated GAGs, such as chondroitin sulfate, dermatan sulfate and keratan sulfate, had no effect on the invasion process. In addition, a significant decrease in infection occurred after interaction of amastigotes with GAG-deficient Chinese Hamster Ovary (CHO) cells, decreasing from 20% and 28% in wild-type CHO cells to 5% and 9% in the mutant cells after 2 h and 4 h of infection, respectively. These findings suggest that amastigote invasion also involves host cell surface heparan sulfate proteoglycans. The knowledge of the mechanism triggered by heparan sulfate-binding T. cruzi proteins may provide new potential candidates for Chagas disease therapy.


Asunto(s)
Enfermedad de Chagas/parasitología , Proteoglicanos de Heparán Sulfato/metabolismo , Heparina/farmacología , Heparitina Sulfato/farmacología , Trypanosoma cruzi/fisiología , Animales , Células CHO , Adhesión Celular/efectos de los fármacos , Membrana Celular/metabolismo , Células Cultivadas , Cricetinae , Cricetulus , Citometría de Flujo , Interacciones Huésped-Parásitos/efectos de los fármacos , Ratones , Microscopía Electrónica de Transmisión , Mutación , Miocitos Cardíacos/parasitología , Factores de Tiempo , Trypanosoma cruzi/efectos de los fármacos , Trypanosoma cruzi/patogenicidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA